The Effects of RPL554 on Top of Standard COPD Reliever Medications
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This study evaluates the addition of RPL554 to standard reliever medications for chronic
obstructive pulmonary disorder (COPD). All patients will receive the same six treatments in a
randomised sequence:
1. salbutamol,
2. ipratropium,
3. salbutamol + RPL554,
4. ipratropium + RPL554,
5. RPL554
6. Placebo